Animal Pharmaceutical-North America Market Status and Trend Report 2013-2023
Report Summary
Animal Pharmaceutical-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Pharmaceutical industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Animal Pharmaceutical 2013-2017, and development forecast 2018-2023
Main market players of Animal Pharmaceutical in North America, with company and product introduction, position in the Animal Pharmaceutical market
Market status and development trend of Animal Pharmaceutical by types and applications
Cost and profit status of Animal Pharmaceutical, and marketing status
Market growth drivers and challenges
The report segments the North America Animal Pharmaceutical market as:
North America Animal Pharmaceutical Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Animal Pharmaceutical Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Vaccine
Veterinary Drugs
Other
North America Animal Pharmaceutical Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Companion Animal
Poultry
Other
North America Animal Pharmaceutical Market: Players Segment Analysis (Company and Product introduction, Animal Pharmaceutical Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Merck
Merial
Elanco
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Virbac
Ceva Sante Animale
V?toquinol
Jurox
MSD Animal Health Australia
PARNELL
CAHIC
Ringpu Biology
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Animal Pharmaceutical-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Pharmaceutical industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Animal Pharmaceutical 2013-2017, and development forecast 2018-2023
Main market players of Animal Pharmaceutical in North America, with company and product introduction, position in the Animal Pharmaceutical market
Market status and development trend of Animal Pharmaceutical by types and applications
Cost and profit status of Animal Pharmaceutical, and marketing status
Market growth drivers and challenges
The report segments the North America Animal Pharmaceutical market as:
North America Animal Pharmaceutical Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Animal Pharmaceutical Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Vaccine
Veterinary Drugs
Other
North America Animal Pharmaceutical Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Companion Animal
Poultry
Other
North America Animal Pharmaceutical Market: Players Segment Analysis (Company and Product introduction, Animal Pharmaceutical Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Merck
Merial
Elanco
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Virbac
Ceva Sante Animale
V?toquinol
Jurox
MSD Animal Health Australia
PARNELL
CAHIC
Ringpu Biology
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ANIMAL PHARMACEUTICAL
1.1 Definition of Animal Pharmaceutical in This Report
1.2 Commercial Types of Animal Pharmaceutical
1.2.1 Vaccine
1.2.2 Veterinary Drugs
1.2.3 Other
1.3 Downstream Application of Animal Pharmaceutical
1.3.1 Companion Animal
1.3.2 Poultry
1.3.3 Other
1.4 Development History of Animal Pharmaceutical
1.5 Market Status and Trend of Animal Pharmaceutical 2013-2023
1.5.1 North America Animal Pharmaceutical Market Status and Trend 2013-2023
1.5.2 Regional Animal Pharmaceutical Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Pharmaceutical in North America 2013-2017
2.2 Consumption Market of Animal Pharmaceutical in North America by Regions
2.2.1 Consumption Volume of Animal Pharmaceutical in North America by Regions
2.2.2 Revenue of Animal Pharmaceutical in North America by Regions
2.3 Market Analysis of Animal Pharmaceutical in North America by Regions
2.3.1 Market Analysis of Animal Pharmaceutical in United States 2013-2017
2.3.2 Market Analysis of Animal Pharmaceutical in Canada 2013-2017
2.3.3 Market Analysis of Animal Pharmaceutical in Mexico 2013-2017
2.4 Market Development Forecast of Animal Pharmaceutical in North America 2018-2023
2.4.1 Market Development Forecast of Animal Pharmaceutical in North America 2018-2023
2.4.2 Market Development Forecast of Animal Pharmaceutical by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Animal Pharmaceutical in North America by Types
3.1.2 Revenue of Animal Pharmaceutical in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Animal Pharmaceutical in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Pharmaceutical in North America by Downstream Industry
4.2 Demand Volume of Animal Pharmaceutical by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Pharmaceutical by Downstream Industry in United States
4.2.2 Demand Volume of Animal Pharmaceutical by Downstream Industry in Canada
4.2.3 Demand Volume of Animal Pharmaceutical by Downstream Industry in Mexico
4.3 Market Forecast of Animal Pharmaceutical in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL PHARMACEUTICAL
5.1 North America Economy Situation and Trend Overview
5.2 Animal Pharmaceutical Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL PHARMACEUTICAL MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Animal Pharmaceutical in North America by Major Players
6.2 Revenue of Animal Pharmaceutical in North America by Major Players
6.3 Basic Information of Animal Pharmaceutical by Major Players
6.3.1 Headquarters Location and Established Time of Animal Pharmaceutical Major Players
6.3.2 Employees and Revenue Level of Animal Pharmaceutical Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL PHARMACEUTICAL MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis
7.1.1 Company profile
7.1.2 Representative Animal Pharmaceutical Product
7.1.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Merck
7.2.1 Company profile
7.2.2 Representative Animal Pharmaceutical Product
7.2.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Merck
7.3 Merial
7.3.1 Company profile
7.3.2 Representative Animal Pharmaceutical Product
7.3.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Merial
7.4 Elanco
7.4.1 Company profile
7.4.2 Representative Animal Pharmaceutical Product
7.4.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Elanco
7.5 Bayer Animal Health
7.5.1 Company profile
7.5.2 Representative Animal Pharmaceutical Product
7.5.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Bayer Animal Health
7.6 Boehringer Ingelheim Vetmedica
7.6.1 Company profile
7.6.2 Representative Animal Pharmaceutical Product
7.6.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim Vetmedica
7.7 Virbac
7.7.1 Company profile
7.7.2 Representative Animal Pharmaceutical Product
7.7.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Virbac
7.8 Ceva Sante Animale
7.8.1 Company profile
7.8.2 Representative Animal Pharmaceutical Product
7.8.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
7.9 V?toquinol
7.9.1 Company profile
7.9.2 Representative Animal Pharmaceutical Product
7.9.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of V?toquinol
7.10 Jurox
7.10.1 Company profile
7.10.2 Representative Animal Pharmaceutical Product
7.10.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Jurox
7.11 MSD Animal Health Australia
7.11.1 Company profile
7.11.2 Representative Animal Pharmaceutical Product
7.11.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of MSD Animal Health Australia
7.12 PARNELL
7.12.1 Company profile
7.12.2 Representative Animal Pharmaceutical Product
7.12.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of PARNELL
7.13 CAHIC
7.13.1 Company profile
7.13.2 Representative Animal Pharmaceutical Product
7.13.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of CAHIC
7.14 Ringpu Biology
7.14.1 Company profile
7.14.2 Representative Animal Pharmaceutical Product
7.14.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Ringpu Biology
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL PHARMACEUTICAL
8.1 Industry Chain of Animal Pharmaceutical
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL PHARMACEUTICAL
9.1 Cost Structure Analysis of Animal Pharmaceutical
9.2 Raw Materials Cost Analysis of Animal Pharmaceutical
9.3 Labor Cost Analysis of Animal Pharmaceutical
9.4 Manufacturing Expenses Analysis of Animal Pharmaceutical
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL PHARMACEUTICAL
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Animal Pharmaceutical in This Report
1.2 Commercial Types of Animal Pharmaceutical
1.2.1 Vaccine
1.2.2 Veterinary Drugs
1.2.3 Other
1.3 Downstream Application of Animal Pharmaceutical
1.3.1 Companion Animal
1.3.2 Poultry
1.3.3 Other
1.4 Development History of Animal Pharmaceutical
1.5 Market Status and Trend of Animal Pharmaceutical 2013-2023
1.5.1 North America Animal Pharmaceutical Market Status and Trend 2013-2023
1.5.2 Regional Animal Pharmaceutical Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Pharmaceutical in North America 2013-2017
2.2 Consumption Market of Animal Pharmaceutical in North America by Regions
2.2.1 Consumption Volume of Animal Pharmaceutical in North America by Regions
2.2.2 Revenue of Animal Pharmaceutical in North America by Regions
2.3 Market Analysis of Animal Pharmaceutical in North America by Regions
2.3.1 Market Analysis of Animal Pharmaceutical in United States 2013-2017
2.3.2 Market Analysis of Animal Pharmaceutical in Canada 2013-2017
2.3.3 Market Analysis of Animal Pharmaceutical in Mexico 2013-2017
2.4 Market Development Forecast of Animal Pharmaceutical in North America 2018-2023
2.4.1 Market Development Forecast of Animal Pharmaceutical in North America 2018-2023
2.4.2 Market Development Forecast of Animal Pharmaceutical by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Animal Pharmaceutical in North America by Types
3.1.2 Revenue of Animal Pharmaceutical in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Animal Pharmaceutical in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Pharmaceutical in North America by Downstream Industry
4.2 Demand Volume of Animal Pharmaceutical by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Pharmaceutical by Downstream Industry in United States
4.2.2 Demand Volume of Animal Pharmaceutical by Downstream Industry in Canada
4.2.3 Demand Volume of Animal Pharmaceutical by Downstream Industry in Mexico
4.3 Market Forecast of Animal Pharmaceutical in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL PHARMACEUTICAL
5.1 North America Economy Situation and Trend Overview
5.2 Animal Pharmaceutical Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL PHARMACEUTICAL MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Animal Pharmaceutical in North America by Major Players
6.2 Revenue of Animal Pharmaceutical in North America by Major Players
6.3 Basic Information of Animal Pharmaceutical by Major Players
6.3.1 Headquarters Location and Established Time of Animal Pharmaceutical Major Players
6.3.2 Employees and Revenue Level of Animal Pharmaceutical Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL PHARMACEUTICAL MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis
7.1.1 Company profile
7.1.2 Representative Animal Pharmaceutical Product
7.1.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Merck
7.2.1 Company profile
7.2.2 Representative Animal Pharmaceutical Product
7.2.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Merck
7.3 Merial
7.3.1 Company profile
7.3.2 Representative Animal Pharmaceutical Product
7.3.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Merial
7.4 Elanco
7.4.1 Company profile
7.4.2 Representative Animal Pharmaceutical Product
7.4.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Elanco
7.5 Bayer Animal Health
7.5.1 Company profile
7.5.2 Representative Animal Pharmaceutical Product
7.5.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Bayer Animal Health
7.6 Boehringer Ingelheim Vetmedica
7.6.1 Company profile
7.6.2 Representative Animal Pharmaceutical Product
7.6.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim Vetmedica
7.7 Virbac
7.7.1 Company profile
7.7.2 Representative Animal Pharmaceutical Product
7.7.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Virbac
7.8 Ceva Sante Animale
7.8.1 Company profile
7.8.2 Representative Animal Pharmaceutical Product
7.8.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
7.9 V?toquinol
7.9.1 Company profile
7.9.2 Representative Animal Pharmaceutical Product
7.9.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of V?toquinol
7.10 Jurox
7.10.1 Company profile
7.10.2 Representative Animal Pharmaceutical Product
7.10.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Jurox
7.11 MSD Animal Health Australia
7.11.1 Company profile
7.11.2 Representative Animal Pharmaceutical Product
7.11.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of MSD Animal Health Australia
7.12 PARNELL
7.12.1 Company profile
7.12.2 Representative Animal Pharmaceutical Product
7.12.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of PARNELL
7.13 CAHIC
7.13.1 Company profile
7.13.2 Representative Animal Pharmaceutical Product
7.13.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of CAHIC
7.14 Ringpu Biology
7.14.1 Company profile
7.14.2 Representative Animal Pharmaceutical Product
7.14.3 Animal Pharmaceutical Sales, Revenue, Price and Gross Margin of Ringpu Biology
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL PHARMACEUTICAL
8.1 Industry Chain of Animal Pharmaceutical
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL PHARMACEUTICAL
9.1 Cost Structure Analysis of Animal Pharmaceutical
9.2 Raw Materials Cost Analysis of Animal Pharmaceutical
9.3 Labor Cost Analysis of Animal Pharmaceutical
9.4 Manufacturing Expenses Analysis of Animal Pharmaceutical
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL PHARMACEUTICAL
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
